Plitidepsin in patients with advanced colorectal cancer (CRC): Results of an exploratory phase II trial

被引：0
|
作者：
Tabernero, Josep M.
Rivera, Fernando
Casado, Esther
Sanchez, Antonio
Bezares, Susana
Pico, Cesar
Paz-Ares, Luis
机构：
[1] Hosp Gen Valle Hebron, Barcelona, Spain
[2] Univ Marques Valdecilla, Santander, Spain
[3] Clin Puerta Hierro, Madrid, Spain
[4] PharmaMar SAU, Madrid, Spain
[5] Univ Madrid, Hosp 12 Octubre, Madrid 3, Spain
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [41] Phase II trial of curcumin in patients with advanced pancreatic cancer
    Dhillon, Navneet
    Aggarwal, Bharat B.
    Newman, Robert A.
    Wolff, Robert A.
    Kunnumakkara, Ajaikumar B.
    Abbruzzese, James L.
    Ng, Chaan S.
    Badmaev, Vladimir
    Kurzrock, Razelle
    CLINICAL CANCER RESEARCH, 2008, 14 (14) : 4491 - 4499
  • [42] Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer
    Redman, BG
    Esper, P
    Pan, QT
    Dunn, RL
    Hussain, HK
    Chenevert, T
    Brewer, GJ
    Merajver, SD
    CLINICAL CANCER RESEARCH, 2003, 9 (05) : 1666 - 1672
  • [43] PHASE-II TRIAL OF RETINOL IN PATIENTS WITH ADVANCED CANCER
    GOODMAN, GE
    CANCER TREATMENT REPORTS, 1986, 70 (08): : 1023 - 1024
  • [44] A phase II trial of FUdR in patients with advanced pancreatic cancer
    Bach Ardalan
    Mayra Lima
    Journal of Cancer Research and Clinical Oncology, 2004, 130 : 561 - 566
  • [45] A phase II trial of FUdR in patients with advanced pancreatic cancer
    Ardalan, B
    Lima, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (10) : 561 - 566
  • [46] S-1 in colorectal cancer (CRC):: Interim results of an early phase II study.
    Vermorken, J
    Schöffski, P
    Schellens, J
    Roth, A
    Duffaud, F
    Bruntsch, U
    Reinke, F
    Wanders, J
    De Boer, R
    Fumoleau, P
    ANNALS OF ONCOLOGY, 2000, 11 : 60 - 60
  • [47] Final Results of a Phase II Trial with Plitidepsin (Aplidin) Alone and in Combination with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
    Mateos, Maria-Victoria
    Cibeira, Teresa
    Richardson, Paul
    Blade, Joan
    Prosper, Felipe
    Oriol, Albert
    de la Rubia, Javier
    Alegre, Adrian
    Lahuerta, Juan Jose
    Garcia-Sanz, Ramon
    Mitsiades, Constantine S.
    Espinoza, Jose
    Anderson, Kenneth C.
    Miguel, J. F. San
    BLOOD, 2008, 112 (11) : 1268 - 1268
  • [48] Phase II clinical trial with axitinib as maintenance therapy in patients (p) with metastatic colorectal carcinoma (CRC)
    Gravalos, C.
    Carrato, A.
    Tobena, M.
    Grande Pulido, E.
    Soler, G.
    Vieitez, J.
    Robles, L.
    Valladares-Ayerbes, M.
    Polo, E.
    Limon, M. L.
    Safont, M. J.
    Lopez, C.
    Garcia Alfonso, P.
    Aranda, E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [49] A phase II trial of lapatinib and capecitabine for patients with refractory advanced colorectal adenocarcinoma
    Frank, D. J.
    LoConte, N. K.
    Brooks, W.
    Kim, K.
    Mulkerin, D.
    Schelman, W. R.
    Jumonville, A.
    Holen, K. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma
    Delloukina, ML
    Prager, D
    Parson, M
    Hecht, JR
    Rosen, P
    Rosen, LS
    CANCER, 2002, 94 (08) : 2174 - 2179
12345